Endothelial glycocalyx during early reperfusion in patients undergoing cardiac surgery.

<h4>Background</h4>Experimental cardiac ischemia-reperfusion injury causes degradation of the glycocalyx and coronary washout of its components syndecan-1 and heparan sulfate. Systemic elevation of syndecan-1 and heparan sulfate is well described in cardiac surgery. Still, the events dur...

Full description

Bibliographic Details
Main Authors: Arie Passov, Alexey Schramko, Ulla-Stina Salminen, Juha Aittomäki, Sture Andersson, Eero Pesonen
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2021-01-01
Series:PLoS ONE
Online Access:https://doi.org/10.1371/journal.pone.0251747
id doaj-18a50d08e77d467eaad0942048228ec3
record_format Article
spelling doaj-18a50d08e77d467eaad0942048228ec32021-05-30T04:30:44ZengPublic Library of Science (PLoS)PLoS ONE1932-62032021-01-01165e025174710.1371/journal.pone.0251747Endothelial glycocalyx during early reperfusion in patients undergoing cardiac surgery.Arie PassovAlexey SchramkoUlla-Stina SalminenJuha AittomäkiSture AnderssonEero Pesonen<h4>Background</h4>Experimental cardiac ischemia-reperfusion injury causes degradation of the glycocalyx and coronary washout of its components syndecan-1 and heparan sulfate. Systemic elevation of syndecan-1 and heparan sulfate is well described in cardiac surgery. Still, the events during immediate reperfusion after aortic declamping are unknown both in the systemic and in the coronary circulation.<h4>Methods</h4>In thirty patients undergoing aortic valve replacement, arterial concentrations of syndecan-1 and heparan sulfate were measured immediately before and at one, five and ten minutes after aortic declamping (reperfusion). Parallel blood samples were drawn from the coronary sinus to calculate trans-coronary gradients (coronary sinus-artery).<h4>Results</h4>Compared with immediately before aortic declamping, arterial syndecan-1 increased by 18% [253.8 (151.6-372.0) ng/ml vs. 299.1 (172.0-713.7) ng/ml, p < 0.001] but arterial heparan sulfate decreased by 14% [148.1 (135.7-161.7) ng/ml vs. 128.0 (119.0-138.2) ng/ml, p < 0.001] at one minute after aortic declamping. There was no coronary washout of syndecan-1 or heparan sulfate during reperfusion. On the contrary, trans-coronary sequestration of syndecan-1 occurred at five [-12.96 ng/ml (-36.38-5.15), p = 0.007] and at ten minutes [-12.37 ng/ml (-31.80-6.62), p = 0.049] after reperfusion.<h4>Conclusions</h4>Aortic declamping resulted in extracardiac syndecan-1 release and extracardiac heparan sulfate sequestration. Syndecan-1 was sequestered in the coronary circulation during early reperfusion. Glycocalyx has been shown to degrade during cardiac surgery. Besides degradation, glycocalyx has propensity for regeneration. The present results of syndecan-1 and heparan sulfate sequestration may reflect endogenous restoration of the damaged glycocalyx in open heart surgery.https://doi.org/10.1371/journal.pone.0251747
collection DOAJ
language English
format Article
sources DOAJ
author Arie Passov
Alexey Schramko
Ulla-Stina Salminen
Juha Aittomäki
Sture Andersson
Eero Pesonen
spellingShingle Arie Passov
Alexey Schramko
Ulla-Stina Salminen
Juha Aittomäki
Sture Andersson
Eero Pesonen
Endothelial glycocalyx during early reperfusion in patients undergoing cardiac surgery.
PLoS ONE
author_facet Arie Passov
Alexey Schramko
Ulla-Stina Salminen
Juha Aittomäki
Sture Andersson
Eero Pesonen
author_sort Arie Passov
title Endothelial glycocalyx during early reperfusion in patients undergoing cardiac surgery.
title_short Endothelial glycocalyx during early reperfusion in patients undergoing cardiac surgery.
title_full Endothelial glycocalyx during early reperfusion in patients undergoing cardiac surgery.
title_fullStr Endothelial glycocalyx during early reperfusion in patients undergoing cardiac surgery.
title_full_unstemmed Endothelial glycocalyx during early reperfusion in patients undergoing cardiac surgery.
title_sort endothelial glycocalyx during early reperfusion in patients undergoing cardiac surgery.
publisher Public Library of Science (PLoS)
series PLoS ONE
issn 1932-6203
publishDate 2021-01-01
description <h4>Background</h4>Experimental cardiac ischemia-reperfusion injury causes degradation of the glycocalyx and coronary washout of its components syndecan-1 and heparan sulfate. Systemic elevation of syndecan-1 and heparan sulfate is well described in cardiac surgery. Still, the events during immediate reperfusion after aortic declamping are unknown both in the systemic and in the coronary circulation.<h4>Methods</h4>In thirty patients undergoing aortic valve replacement, arterial concentrations of syndecan-1 and heparan sulfate were measured immediately before and at one, five and ten minutes after aortic declamping (reperfusion). Parallel blood samples were drawn from the coronary sinus to calculate trans-coronary gradients (coronary sinus-artery).<h4>Results</h4>Compared with immediately before aortic declamping, arterial syndecan-1 increased by 18% [253.8 (151.6-372.0) ng/ml vs. 299.1 (172.0-713.7) ng/ml, p < 0.001] but arterial heparan sulfate decreased by 14% [148.1 (135.7-161.7) ng/ml vs. 128.0 (119.0-138.2) ng/ml, p < 0.001] at one minute after aortic declamping. There was no coronary washout of syndecan-1 or heparan sulfate during reperfusion. On the contrary, trans-coronary sequestration of syndecan-1 occurred at five [-12.96 ng/ml (-36.38-5.15), p = 0.007] and at ten minutes [-12.37 ng/ml (-31.80-6.62), p = 0.049] after reperfusion.<h4>Conclusions</h4>Aortic declamping resulted in extracardiac syndecan-1 release and extracardiac heparan sulfate sequestration. Syndecan-1 was sequestered in the coronary circulation during early reperfusion. Glycocalyx has been shown to degrade during cardiac surgery. Besides degradation, glycocalyx has propensity for regeneration. The present results of syndecan-1 and heparan sulfate sequestration may reflect endogenous restoration of the damaged glycocalyx in open heart surgery.
url https://doi.org/10.1371/journal.pone.0251747
work_keys_str_mv AT ariepassov endothelialglycocalyxduringearlyreperfusioninpatientsundergoingcardiacsurgery
AT alexeyschramko endothelialglycocalyxduringearlyreperfusioninpatientsundergoingcardiacsurgery
AT ullastinasalminen endothelialglycocalyxduringearlyreperfusioninpatientsundergoingcardiacsurgery
AT juhaaittomaki endothelialglycocalyxduringearlyreperfusioninpatientsundergoingcardiacsurgery
AT stureandersson endothelialglycocalyxduringearlyreperfusioninpatientsundergoingcardiacsurgery
AT eeropesonen endothelialglycocalyxduringearlyreperfusioninpatientsundergoingcardiacsurgery
_version_ 1721421166819672064